China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -17.87% | -13.80% | -10.79% | -1.55% | 8.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.87% | -13.80% | -10.79% | -1.55% | 8.98% |
| Cost of Revenue | -17.21% | -13.20% | -10.22% | -2.70% | 5.49% |
| Gross Profit | -18.08% | -14.00% | -10.98% | -1.17% | 10.19% |
| SG&A Expenses | -19.46% | -15.47% | -12.58% | -4.37% | 4.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.46% | -14.83% | -12.31% | -4.34% | 4.38% |
| Operating Income | -15.70% | -10.00% | -5.13% | 9.81% | 29.82% |
| Income Before Tax | -9.42% | 4.05% | 16.98% | 22.20% | 29.09% |
| Income Tax Expenses | 10.10% | 8.93% | 6.93% | 17.57% | 34.09% |
| Earnings from Continuing Operations | -14.91% | 2.56% | 20.32% | 23.61% | 27.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.91% | 2.56% | 20.32% | 23.61% | 27.75% |
| EBIT | -15.70% | -10.00% | -5.13% | 9.81% | 29.82% |
| EBITDA | -17.87% | -10.85% | -5.48% | 6.65% | 21.95% |
| EPS Basic | -14.83% | 2.58% | 20.38% | 23.60% | 27.66% |
| Normalized Basic EPS | -9.89% | 3.87% | 17.19% | 22.49% | 29.42% |
| EPS Diluted | -14.88% | 2.58% | 20.38% | 23.60% | 27.66% |
| Normalized Diluted EPS | -9.89% | 3.87% | 17.19% | 22.49% | 29.42% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 23.39% | 23.39% | 23.39% | 23.13% | 22.87% |
| Payout Ratio | 0.47% | 0.22% | 0.03% | 0.00% | -0.03% |